T3 Live
Shares

Why David Prince Likes VKTX

Shares

David Prince remains bullish the biotech space headed into the end of the year… specifically Viking Therapeutics (VKTX).

Watch the video below to hear why he says the addressable market of the weight loss drug space is “bigger than most things we've ever witnessed”:

David also discusses:

  • Expectations for VKTX ahead of key data being released in November
  • How the end of year setup in XBI is similar to 2023
  • How small caps should perform in Q4
  • How he's finding alpha with Chinese stocks

Want to trade with David? Apply to join the Inner Circle now!

Leave a Comment: